Has Raj Wadwa received payments from drug or device companies?

Yes. Drug and device makers reported $60,703 in general payments to Raj Wadwa across 73 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raj Wadwa did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raj Wadwa come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raj Wadwa

Pediatric Endocrinology · Aurora, CONPI 1528072840

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Dexcom, Inc. at 39.7% of the total. Reporting peaked in 2019 at $16,681 and has fallen 56.6% since, to $7,233 in 2025.

$60,703in general payments, 2019–2025

Across 73 payments — averaging $831.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Dexcom, Inc.$24K
Tandem Diabetes Care, Inc.$12K
Eli Lilly$11K
Medtronic$10K
Lilly USA, LLC$3K
Sanofi-aventis U.S. LLC$252
plus $84 from 1 others

$883,684in research payments, 2019–2025

Across 28 payments — averaging $31,560 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$570K
Dexcom, Inc.$303K
Mannkind Corporation$10K

What the payments were for

Consulting fees$25,82843%
Speaking & faculty fees$13,27522%
Travel & lodging$18,10730%
Food & beverage$3,4936%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Dexcom, Inc.	14	$24,110
Tandem Diabetes Care, Inc.	15	$11,815
Eli Lilly	16	$11,060
Medtronic(2 entities)	23	$10,495
Lilly USA, LLC	1	$2,888
Sanofi-aventis U.S. LLC	3	$252
Mannkind Corporation	1	$84

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DEXCOM G6 TRANSMITTER$13,805
DEXCOM G7 GSS (161)$9,378
t:slim X2 insulin pump$4,500
t-slim insulin pump$3,650
t:slim X2 Insulin Pump with Control-IQ$3,468
Minimed 670G System$3,380
MINIMED 780G$1,566
HUMALOG$1,150
TZIELD$112
DEXCOM CGM$104
DEXCOM G6 CGM SYSTEM$102

How this compares

$60,703 in reported general payments places this provider in the 85th percentile of 34 pediatric endocrinology providers in Colorado.

See all pediatric endocrinology providers in Colorado →

Other pediatric endocrinology in Aurora

Kimberly SimmonsAurora$323K
Gregory ForlenzaAurora$200K
Marian RewersAurora$178K
Philip ZeitlerAurora$58K
Andrea SteckAurora$33K
Erin CobryAurora$15K
Georgeanna KlingensmithAurora$14K
Melanie CreeAurora$13K
Natalie NokoffAurora$13K
Robert SloverAurora$6K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →